Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
11,860,351
-
Shares change
-
+29,707
-
Total reported value, excl. options
-
$25,020,069
-
Value change
-
-$3,074,841
-
Put/Call ratio
-
117%
-
Number of buys
-
42
-
Number of sells
-
24
-
Price
-
$2.11
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q4 2022
As of 31 Dec 2022 Humacyte, Inc. - COM (HUMA) had 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,860,351 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Prescott General Partners LLC, NORTHERN TRUST CORP, STATE STREET CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, LPL Financial LLC, Bank of New York Mellon Corp, and Nuveen Asset Management, LLC.
This table shows 90 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.